|
|
Full Coverage
|
|
In-depth coverage about
Biological Warfare
|
|
Related News Stories
|
| · |
World leaders seek biological weapons plan - Financial Times
(Jul 9, 2002) |
| · |
Trials of 50-Year-Old Smallpox Vaccine Underway in U.S. - LA
Times (registration req'd) (Jul 9, 2002) |
| · |
Study Favors Different Tack on Smallpox - NY Times
(registration req'd) (Jul 9, 2002) |
|
More... |
|
Opinion & Editorials
|
| · |
Protection puzzle - New Orleans Times-Picayune (Jul 9, 2002) |
| · |
The next big threat will be biological - The Guardian (UK).
(Jul 3, 2002) |
| · |
Local bioterrorism funding brings up national questions -
Abilene Reporter-News (Jun 27, 2002) |
|
More... |
|
Feature Articles
|
| · |
Russia's Poorly Guarded Past - Washington Post (Jun 17,
2002) |
| · |
Report card on security - USA Today (Jun 7, 2002) |
|
Related Web Sites
|
| · |
NOVA: Bioterror - companion site to PBS show, examines the
risks of bioterrorism and possible defenses. |
| · |
Biological and Chemical Weapons: What They Are and What They Do
- interactive explainer from CNN. |
| · |
FAQ: Biological Agents and Chemicals as Weapons - answers to
common questions on biological warfare, from the World Health
Organization. |
|
More... |
|
|
Pregnant Women Need Smallpox Vaccine During Attack
Mon Jul 8, 2:38 PM ET
By Alison McCook
NEW YORK (Reuters Health) - The smallpox vaccine can hurt a fetus, so
pregnant women are normally not vaccinated against the disease. But if
smallpox is ever intentionally released by bioterrorists, Texas researchers
say, pregnant women exposed to the virus should be given the vaccine to
protect them from the disease that can kill both mother and child.
"In the event of a woman being at risk from smallpox...the risks to the
mother and fetus from experiencing clinical smallpox, especially hemorrhagic
smallpox, substantially outweigh any potential risks regarding vaccination,"
lead author Dr. Victor R. Suarez of the University of Texas Medical Branch
at Galveston told Reuters Health.
Hemorrhagic smallpox is a relatively rare form of smallpox that is
especially deadly, killing 99% of infected people who have not been
vaccinated. It also disproportionately infects pregnant women, but the
reason why is unclear.
Suarez and his co-author, Dr. Gary D.V. Hankins, base their
recommendation on a review of literature concerning the risks of smallpox
and its vaccine for pregnant women. They report their findings in the July
issue of Obstetrics & Gynecology.
The disease--a deadly blistering of the skin accompanied by pain and
fever--was wiped out in 1979 after a worldwide public health effort, but
military strategists are concerned that virus samples produced in the Soviet
Union during the Cold War could fall into the hands of militant groups or
rogue states.
In the event of an outbreak, current US policy calls for isolation of
victims and vaccination of anyone suspected to have come into contact with
infected patients. There is currently no specific treatment for smallpox.
The smallpox vaccine is now offered to laboratory workers who handle the
deadly virus. Calls for a broader vaccination program escalated after the
Sept. 11 attacks and a subsequent outbreak of anthrax, which killed five
people in the US.
In October 2001, the US government ordered the production of more than
200 million doses of smallpox vaccine and expects to have enough stockpiled
by 2003 to protect every citizen from a biological attack.
Side effects from vaccination include death in about 0.5 to 5 per 1
million people who receive it, a potentially lethal inflammation of brain
tissue known as encephalitis, infections, and moderate to severe lesions at
or away from the site of vaccination. In addition, a fetus can develop
complications from the vaccine that can result in miscarriage or stillbirth.
Consequently, current vaccination policy suggests that certain people
should not be vaccinated against smallpox, including pregnant women, people
with weak immune systems and those who are allergic to the vaccine
ingredients.
However, a previous study of pregnant women exposed to smallpox found
that they were seven times more likely to acquire hemorrhagic smallpox than
their peers, and all of them died from the disease.
As such, the effects of the disease far outweigh the possible risks of
the vaccine for pregnant women, causing Suarez and Hankins to recommend
pregnant women opt for vaccination in the event of an outbreak.
The doctors also urged their colleagues to learn to recognize the early
symptoms of smallpox in their female patients, whether pregnant or not. "Our
degree of preparedness and quickness to diagnose and respond to a
bioterrorism attack are extremely important to avert a great tragedy," they
write.
SOURCE: Obstetrics & Gynecology 2002;100:87-93.
Email this story -
View most popular |
Printer-friendly format
| Archived Stories by Date: |
ADVERTISEMENT
|